AbbVie to raise up to $28B in debt offering to fund Allergan buy

According to Bloomberg, AbbVie (NYSE:ABBV) is looking to raise as much as $28B in a bond offering to fund its Allergan takeover. If so, it would be the fourth largest corporate bond deal ever in the U.S. and the largest since CVS Health’s $40B deal in March 2018 to fund the Aetna acquisition.

https://seekingalpha.com/news/3517155-abbvie-raise-28b-debt-offering-fund-allergan-buy